The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution
Open Access
- 12 December 1997
- journal article
- Published by Wiley in FEBS Letters
- Vol. 418 (3) , 297-300
- https://doi.org/10.1016/s0014-5793(97)01398-7
Abstract
Amyloid fibril formation and deposition are the basis for a wide range of diseases, including spongiform encephalopathies, Alzheimer's and familial amyloidotic polyneuropathies. However, the molecula...Keywords
This publication has 17 references indexed in Scilit:
- Thyroxine binding to transthyretin Met 119Endocrine, 1997
- ‘In vitro’ amyloid fibril formation from transthyretin: the influence of ions and the amyloidogenicity of TTR variantsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1996
- Hypokalemic periodic paralysis mutations: Confirmation of mutation and analysis of founder effectNeuromuscular Disorders, 1996
- Comparison of Lethal and Nonlethal Transthyretin Variants and Their Relationship to Amyloid DiseaseBiochemistry, 1995
- Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitroBiochemistry, 1992
- Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvementHuman Genetics, 1992
- Biochemical and clinical characterization of prealbumin CHICAGO: An apparently benign variant of serum prealbumin (transthyretin) discovered with high‐resolution two‐dimensional electrophoresisAmerican Journal of Medical Genetics, 1991
- Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP)Biochemistry, 1991
- Characterization and stereochemistry of cofactor oxidation by a type II dihydrofolate reductaseBiochemistry, 1990
- A PECULIAR FORM OF PERIPHERAL NEUROPATHYBrain, 1952